Clinical Trial Update: Neuromonitoring in Patients During Aortic Valve Replacement [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating neuromonitoring in patients undergoing aortic valve replacement to reduce the risk of brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury

Snippet

Sponsor: Marija Bozhinovska | Conditions: Brain Injury | Phase 3 | Status: UNKNOWN